Future Science Group launches new initiative, PharmaPlatforms

Recognising the need for cohesive and collaborative communication plans around published content, Future Science Group (FSG; London, UK) is delighted to announce the launch of a new arm of its business, PharmaPlatforms. Taking published content from FSG’s journals, knowledge networks and content hubs, PharmaPlatforms will provide a range of solutions that enrich the information presented,…

Details

Tumor microenvironment analyzed to increase effectiveness of preclinical trials

IMAGE: Analysis of self-organization of MSCs, Hela, and PBMCs after 72 h of co-culture. Arrows indicate fused cells. (A) Alexa Fluor 647 (MSCs), (B) PE (HeLa), (C) FITC (PBMCs), (D, D1,… view more  Credit: Kazan Federal University It was shown that co-culturing HeLa adenocarcinoma cells, peripheral blood mononuclear cells, and mesenchymal stromal cells results in changes…

Details